161 related articles for article (PubMed ID: 38008029)
1. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Blay JY; Tlemsani C; Toulmonde M; Italiano A; Rios M; Bompas E; Valentin T; Duffaud F; Le Nail LR; Watson S; Firmin N; Dubray-Longeras P; Ropars M; Perrin C; Hervieu A; Lebbe C; Saada-Bouzid E; Soibinet P; Fiorenza F; Bertucci F; Boudou P; Vaz G; Bonvalot S; Honoré C; Marec-Berard P; Minard V; Cleirec M; Biau D; Meeus P; Babinet A; Dumaine V; Carriere S; Fau M; Decanter G; Gouin F; Ngo C; Le Loarer F; Karanian M; Meurgey A; Dufresne A; Brahmi M; Chemin-Airiau C; Ducimetiere F; Penel N; Le Cesne A;
Eur J Cancer; 2024 Jan; 196():113454. PubMed ID: 38008029
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
3. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
[TBL] [Abstract][Full Text] [Related]
4. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
5. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
7. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
8. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases.
Rekhi B; Deshmukh M; Jambhekar NA
Ann Diagn Pathol; 2011 Oct; 15(5):303-11. PubMed ID: 21550274
[TBL] [Abstract][Full Text] [Related]
9. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
11. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
Blay JY; Piperno-Neumann S; Watson S; Dufresne A; Valentin T; Duffaud F; Toulmonde M; Italiano A; Bertucci F; Tlemsani C; Firmin N; Bompas E; Perrin C; Ropars M; Saada-Bouzid E; Dubray-Longeras P; Hervieu A; Lebbe C; Gantzer J; Chaigneau L; Fiorenza F; Rios M; Isambert N; Soibinet P; Boudou-Roquette P; Verret B; Ferron G; Ryckewaert T; Lebellec L; Brahmi M; Gouin F; Meeus P; Vaz G; Le Loarer F; Karanian M; De Pinieux G; Ducimetiere F; Chemin C; Morelle M; Le Cesne A; Penel N;
Eur J Cancer; 2023 Oct; 192():113262. PubMed ID: 37625241
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.
Rekhi B; Folpe AL; Deshmukh M; Jambhekar NA
Pathol Oncol Res; 2011 Mar; 17(1):145-8. PubMed ID: 20499220
[TBL] [Abstract][Full Text] [Related]
14. Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
Basse C; Italiano A; Penel N; Mir O; Chemin C; Toulmonde M; Duffaud F; Le Cesne A; Chevreau C; Maynou C; Anract P; Gouin F; Rios M; Firmin N; Kurtz JE; Kerbrat P; Piperno-Neumann S; Bertucci F; Rosset P; Isambert N; Bompas E; Dubray-Longeras P; Fiorenza F; Le Maignan C; Chaigneau L; Thyss A; Bouché O; Eymard JC; Delcambre Lair C; Adam J; Karanian M; Lebbé C; Dupré A; Meeus P; Brahmi M; Dufresne A; Ducimetière F; Ray-Coquard I; Blay JY
Int J Cancer; 2019 Oct; 145(8):2135-2143. PubMed ID: 30924137
[TBL] [Abstract][Full Text] [Related]
15. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
[TBL] [Abstract][Full Text] [Related]
16. Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Blay JY; Honoré C; Stoeckle E; Meeus P; Jafari M; Gouin F; Anract P; Ferron G; Rochwerger A; Ropars M; Carrere S; Marchal F; Sirveaux F; Di Marco A; Le Nail LR; Guiramand J; Vaz G; Machiavello JC; Marco O; Causeret S; Gimbergues P; Fiorenza F; Chaigneau L; Guillemin F; Guilloit JM; Dujardin F; Spano JP; Ruzic JC; Michot A; Soibinet P; Bompas E; Chevreau C; Duffaud F; Rios M; Perrin C; Firmin N; Bertucci F; Le Pechoux C; Le Loarer F; Collard O; Karanian-Philippe M; Brahmi M; Dufresne A; Dupré A; Ducimetière F; Giraud A; Pérol D; Toulmonde M; Ray-Coquard I; Italiano A; Le Cesne A; Penel N; Bonvalot S;
Ann Oncol; 2019 Jul; 30(7):1143-1153. PubMed ID: 31081028
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor.
Murshed KA; Al-Bozom I; Ammar A
APMIS; 2021 Aug; 129(8):455-460. PubMed ID: 34048081
[TBL] [Abstract][Full Text] [Related]
18. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
19. Sclerosing epithelioid fibrosarcoma of the oral cavity.
Elkins CT; Wakely PE
Head Neck Pathol; 2011 Dec; 5(4):428-31. PubMed ID: 21691827
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
